Piper Sandler Maintains Underweight On Canopy Growth Stock, Calls Cannabis Rescheduling 'Largely Symbolic'

A recent company note from Piper Sandler & Co, by senior analysts Michael S. Lavery and Luke Maloney offers insights into Canopy Growth Corporation's (NASDAQ:CGC) financial performance, valuation and

Benzinga15:35

Piper Sandler Reviews Canopy Growth's Q4

Canopy Growth Corporation reported a fourth quarter revenue beat but EBITDA was well below Piper Sandler estimates. Management reaffirmed its expectations to achieve positive adjusted EBITDA in H2 202

MT Newswires11:56

Canopy Growth Corp. Is Maintained at Underperform by CIBC World Markets

Canopy Growth Corp. Is Maintained at Underperform by CIBC World Markets

Dow JonesMay 31 10:49

Canopy Growth Corp. Price Target Cut to C$4.00/Share From C$4.50 by CIBC World Markets

Canopy Growth Corp. Price Target Cut to C$4.00/Share From C$4.50 by CIBC World Markets

Dow JonesMay 31 10:49

Acreage's Q1 Revenue Slips 19% YoY But CEO Foresees 'Significant Growth Opportunities' As Canopy Growth Strategy Moves Forward

Multi-state cannabis operator Acreage Holdings, Inc. (CSE:ACRG, ACRG.B.U))) (OTCQX:ACRHF, ACRDF))), reported its financial results on Friday for the first quarter ended March 31, 2024."In the first qu

BenzingaMay 31 08:07

Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)

TipRanksMay 31 06:10